EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism

Robert Hansford, Sophie Buller, Anthony H Tsang, Simon Benoit, Anna G Roberts, Emmy Erskine, Thomas Brown, Valentina Pirro, Frank Reimann, Norio Harada, Nobuya Inagaki, Ricardo J Samms und 5 weitere

Cell Metabolism · 2025-09 · 37 (9) · 1820-1834.e5

DOI: 10.1016/j.cmet.2025.07.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2025-09. Verfasst von Robert Hansford und 16 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB20QQ, UK. Hauptthemen laut MEDLINE: Oligodendroglia, Receptors, Gastrointestinal Hormone, Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Diabetes UK, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The next generation of obesity medicines harness the activity of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors (GIPR and GLP-1R), but their mechanism of action remains unclear. Here, we report that the GIPR is enriched in oligodendrocytes and GIPR signaling bidirectionally regulates oligodendrogenesis. In mice with adult-onset deletion of GIPR in oligodendrocytes, GIPR agonism fails to enhance the weight-loss effects of GLP-1R agonism. Mechanistically, GIPR agonism increases brain access of GLP-1R agonists, and GIPR signaling in oligodendrocytes is required for this effect. In addition, we show that vasopressin neurons of the paraventricular hypothalamus are necessary for the weight-loss response to GLP-1R activation, targeted by peripherally administered GLP-1R agonists via their axonal compartment, and this access is increased by activation of the GIPR in oligodendrocytes. Collectively, our findings identify a novel mechanism by which incretin therapies may function to promote synergistic weight loss in the management of excess adiposity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligodendrogliaReceptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 Receptor AgonistsWeight LossGlucagon-Like Peptide-1 ReceptorAnimalsSignal TransductionMiceMice, Inbred C57BLMaleGastric Inhibitory PolypeptideMice, KnockoutObesity

Stichwörter der Autor:innen

blood-brain barrierglucose-dependent insulinotropic peptidehypothalamusincretinmedian eminenceobesityoligodendrocytesweight loss

Substanzen

gastric inhibitory polypeptide receptorReceptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 ReceptorGlp1r protein, mouseGastric Inhibitory Polypeptide

Autor:innen und Institutionen

  • Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB20QQ, UK.
  • Department of Neuroscience, Physiology, and Pharmacology, University College London, London, UK.
  • Diabetes, Obesity and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Department of Diabetes, Endocrinology and Nutrition, Kyoto University, Kyoto, Japan.
  • Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
  • Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Förderung

  • Medical Research Council
  • Diabetes UK
  • Wellcome Trust
  • European Research Council
  • UK Research and Innovation Medical Research Council
  • Saint Mary's Foundation
  • Economic and Social Research Council
  • HORIZON EUROPE Framework Programme

Zitieren

APA

Hansford, R., Buller, S., Tsang, A. H., Benoit, S., Roberts, A. G., Erskine, E., Brown, T., Pirro, V., Reimann, F., Harada, N., Inagaki, N., Samms, R. J., Broichhagen, J., Hodson, D. J., Adriaenssens, A., Park, S., & Blouet, C. (2025). Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism. Cell Metabolism, 37(9), 1820-1834.e5. https://doi.org/10.1016/j.cmet.2025.07.009

Vancouver

Hansford R, Buller S, Tsang AH, Benoit S, Roberts AG, Erskine E, et al. Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism. Cell Metabolism. 2025;37(9):1820-1834.e5. doi:10.1016/j.cmet.2025.07.009

BibTeX
@article{Hansford2025,
  author = {Hansford, Robert and Buller, Sophie and Tsang, Anthony H and Benoit, Simon and Roberts, Anna G and Erskine, Emmy and Brown, Thomas and Pirro, Valentina and Reimann, Frank and Harada, Norio and Inagaki, Nobuya and Samms, Ricardo J and Broichhagen, Johannes and Hodson, David J and Adriaenssens, Alice and Park, Soyoung and Blouet, Clemence},
  title = {Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism},
  journal = {Cell Metabolism},
  year = {2025},
  volume = {37},
  number = {9},
  pages = {1820--1834.e5},
  doi = {10.1016/j.cmet.2025.07.009}
}
Kostenlos starten →